Improving transitions and outcomes for heart failure patients receiving home health care
Official title: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF): A Type 1 Hybrid Effectiveness- Implementation Trial
Run by Weill Medical College of Cornell University · NCT06118983 · Data updated 2026-11-12
This study is testing a new program to help heart failure patients move from the hospital to home health care more smoothly and see if it can reduce the chances of them going back to the hospital within 30 days.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1094 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Status | Recruiting |
| Started | July 28, 2026 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2028 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT06118983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults hospitalized for heart failure who will transition to home health care services.
✕Probably not a fit
Patients who are discharged home without home health care or to other facilities like rehabilitation centers or hospice may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance the transition of heart failure patients from hospitals to home health care services through an intervention called I-TRANSFER-HF. The intervention includes early home health nurse visits and timely outpatient medical appointments to reduce hospital readmissions within 30 days. Researchers will compare outcomes before and after implementing I-TRANSFER-HF across various hospital-home health agency pairs, utilizing Medicare claims data and qualitative interviews to assess the intervention's effectiveness and real-world implementation challenges.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce hospital readmissions and improve the overall quality of life for heart failure patients transitioning to home care.
How similar studies have gone: Other studies have shown promise in improving hospital-to-home transitions for heart failure patients, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Aim 1, Inclusion Criteria: * Adults hospitalized for HF who transition from participating hospitals to their partner HHC agency during the study period. Aim 1, Exclusion Criteria: * Patients hospitalized for HF and discharged: home without HHC, or to an inpatient rehabilitation facility, skilled nursing facility, or hospice; patients with end stage renal disease on dialysis and those with left ventricular devices. Aim 2, Inclusion Criteria: \- Healthcare professional involved in the transition of heart failure patients from the acute care setting (hospital) to HHC (home health care) agencies, and the implementation of the I-TRANSFER-HF at one of the four participating hospital-HHC dyads. Aim 2, Exclusion Criteria: \- Healthcare professional not involved in the transition of heart failure patients from the acute care setting (hospital) to HHC (home health care) agencies, and the implementation of the I-TRANSFER-HF at one of the four participating hospital-HHC dyads.
Where it's running
-
VNS Health Partners in Care
New York, New York, United States Recruiting -
Weill Cornell Medicine
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Madeline R Sterling, MD, MPH, MS — Weill Medical College of Cornell University
- Study coordinator: Madeline R Sterling, MD, MPH, MS
- Email: mrs9012@med.cornell.edu
- Phone: 6469625029
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.